Ina Kramer - Publications

Best practices to master robotic preparation of ready-to-administer systemic anticancer therapy in hospital pharmacies.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: August 22, 2026

Sost deficiency leads to greater bone vascular porosity, but similar osteocyte lacunar properties with increasing age.

Journal: Bone reports

Published: May 29, 2026

Discovery and Characterization of Zilurgisertib, a Potent and Selective Inhibitor of Activin Receptor-like Kinase‑2 (ALK2) for the Treatment of Fibrodysplasia Ossificans Progressiva.

Journal: ACS medicinal chemistry letters

Published: August 27, 2025

Surface modified cationic PLGA microparticles as long-acting injectable carriers for intra-articular small molecule drug delivery.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: September 18, 2023

An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling.

Journal: Calcified tissue international

Published: July 10, 2023

Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5.

Journal: Bone research

Published: January 02, 2023

Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva.

Journal: Bioorganic & medicinal chemistry letters

Published: January 28, 2022

Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial.

Journal: Nature medicine

Published: December 06, 2021

Cortical bone adaptation to a moderate level of mechanical loading in male Sost deficient mice.

Journal: Scientific reports

Published: September 01, 2020

Blockage of bone morphogenetic protein signalling counteracts hypertrophy in a human osteoarthritic micro-cartilage model.

Journal: Journal of cell science

Published: May 19, 2020

Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model.

Journal: European cells & materials

Published: May 22, 2019

Effects of Long-Term Sclerostin Deficiency on Trabecular Bone Mass and Adaption to Limb Loading Differ in Male and Female Mice.

Journal: Calcified tissue international

Published: May 12, 2019